Moxifloxacin Stulln (Moxifloxacin)

Moxifloxacin belongs to the fluoroquinolone class and works by inhibiting bacterial DNA gyrase and topoisomerase IV. These enzymes are essential for DNA replication and transcription, so their blockade halts bacterial cell division and leads to bacterial death.

The exact dosing regimen is determined by the prescribing clinician based on the infection type, severity, and patient factors. Typically, a prescribed number of drops are instilled into the affected eye(s) at defined intervals, but the precise schedule must be followed as directed by the healthcare professional.

Safety data for ocular use of moxifloxacin in pregnancy and lactation are limited. The prescriber should evaluate the potential benefits against any possible risks to the fetus or infant and decide whether treatment is appropriate.

To place an order, submit an enquiry on the product page at gnhindia.com, specifying the required quantity. GNH India works with hospitals, pharmacies and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details (including any cold‑chain requirements) and necessary import documentation.

Moxifloxacin offers a broad spectrum of activity against both Gram‑positive and Gram‑negative ocular pathogens and often requires fewer daily administrations compared with older agents like ciprofloxacin. Its enhanced potency can lead to faster symptom resolution, though choice of therapy should be guided by local resistance patterns and clinician preference.

Store the ophthalmic solution at room temperature, below 25 °C, in the original packaging. Protect it from direct sunlight, moisture and extreme temperatures. Keep the container tightly closed when not in use to maintain sterility.

Moxifloxacin Stulln is applied as eye drops. The patient should wash their hands, tilt the head back, pull down the lower eyelid to create a small pocket, and instill the prescribed number of drops into the conjunctival sac. The eye should be closed gently for a few seconds to allow absorption.

Serious adverse events, although rare, include severe allergic reactions such as anaphylaxis, corneal ulceration, significant vision loss, and systemic hypersensitivity syndromes like Stevens‑Johnson syndrome. Any sudden worsening of eye pain, swelling, or visual changes should prompt immediate medical evaluation.

Patients with a known hypersensitivity to moxifloxacin, other fluoroquinolones, or any component of the formulation should avoid this product. It is also contraindicated for viral or fungal eye infections, and should be used with caution in individuals with pre‑existing corneal epithelial defects.